The board of directors of Bal Pharma at its meeting held on Jun. 30, 2007, recommended dividend of 7.5% a share. Bal Pharma was incorporated in 1987. The company is engaged in formulations with products like Zanovid, Aziwin dry syrup, Meloxi, Ocium-M and Progit-MPS. It also has a bulk drug division with prime bulk drug being gliclazide.
Read More
Friday, August 31, 2007
Bal Pharma board recommends 7.5% dividend
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment